Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
T414472-5mg
|
5mg |
5
|
$301.90
|
|
|
T414472-10mg
|
10mg |
3
|
$395.90
|
|
|
T414472-25mg
|
25mg |
2
|
$946.90
|
|
|
T414472-50mg
|
50mg |
1
|
$1,137.90
|
|
|
T414472-100mg
|
100mg |
1
|
$2,048.90
|
|
Fatty Acid Synthase Inhibitors
| Synonyms | Denifanstat | 4-[1-[4-cyclobutyl-2-methyl-5-(5-methyl-1H-1,2,4-triazol-3-yl)benzoyl]piperidin-4-yl]benzonitrile | 1399177-37-7 | FT-0654318 | A937502 | 4GF95B2LZA | Denifanstat [INN] | 3-(t-butoxycarbonylamino)propanoic acid | BDBM137084 | UNII-4GF95B2LZA |
|---|---|
| Specifications & Purity | ≥98% |
| Biochemical and Physiological Mechanisms | TVB-2640 (ASC-40, FASN-IN-2) is an orally bioavailable, pharmacological fatty acid synthase (FAS/FASN) inhibitor with therapeutic potential in patients with NAFLD and nonalcoholic steatohepatitis. |
| Storage Temp | Protected from light,Store at -20°C,Argon charged |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Product Description |
Information TVB-2640 TVB-2640 (ASC-40, FASN-IN-2) is an orally bioavailable, pharmacological fatty acid synthase (FAS/FASN) inhibitor with therapeutic potential in patients with NAFLD and nonalcoholic steatohepatitis. Targets FAS |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Benzenoids |
| Class | Benzene and substituted derivatives |
| Subclass | Benzoyl derivatives |
| Intermediate Tree Nodes | Not available |
| Direct Parent | 1-benzoylpiperidines |
| Alternative Parents | N-benzoylpiperidines Phenylpiperidines Phenyl-1,2,4-triazoles o-Toluamides Benzamides Benzonitriles Tertiary carboxylic acid amides Heteroaromatic compounds Tertiary amines Amino acids and derivatives Nitriles Azacyclic compounds Organooxygen compounds Organic oxides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteromonocyclic compounds |
| Substituents | 1-benzoylpiperidine - N-benzoylpiperidine - Phenylpiperidine - Phenyltriazole - Phenyl-1,2,4-triazole - Benzamide - Benzoic acid or derivatives - O-toluamide - N-acyl-piperidine - Toluamide - Benzonitrile - Toluene - Piperidine - Tertiary carboxylic acid amide - Azole - Heteroaromatic compound - Triazole - 1,2,4-triazole - Amino acid or derivatives - Carboxamide group - Tertiary amine - Nitrile - Carbonitrile - Azacycle - Carboxylic acid derivative - Organoheterocyclic compound - Organonitrogen compound - Hydrocarbon derivative - Amine - Organic oxide - Cyanide - Organic oxygen compound - Organic nitrogen compound - Organooxygen compound - Aromatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as 1-benzoylpiperidines. These are compounds containing a piperidine ring substituted at the 1-position with a benzoyl group. |
| External Descriptors | Not available |
|
|
|
| ALogP | 4.638 |
|---|---|
| HBD Count | 1 |
| Rotatable Bond | 4 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Pubchem Sid | 488202053 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488202053 |
| IUPAC Name | 4-[1-[4-cyclobutyl-2-methyl-5-(5-methyl-1H-1,2,4-triazol-3-yl)benzoyl]piperidin-4-yl]benzonitrile |
| INCHI | InChI=1S/C27H29N5O/c1-17-14-24(22-4-3-5-22)25(26-29-18(2)30-31-26)15-23(17)27(33)32-12-10-21(11-13-32)20-8-6-19(16-28)7-9-20/h6-9,14-15,21-22H,3-5,10-13H2,1-2H3,(H,29,30,31) |
| InChIKey | BBGOSBDSLYHMRA-UHFFFAOYSA-N |
| Smiles | CC1=CC(=C(C=C1C(=O)N2CCC(CC2)C3=CC=C(C=C3)C#N)C4=NNC(=N4)C)C5CCC5 |
| Isomeric SMILES | CC1=CC(=C(C=C1C(=O)N2CCC(CC2)C3=CC=C(C=C3)C#N)C4=NNC(=N4)C)C5CCC5 |
| PubChem CID | 66548316 |
| Molecular Weight | 439.55 |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Sep 21, 2023 | T414472 | |
| Certificate of Analysis | Sep 21, 2023 | T414472 | |
| Certificate of Analysis | Sep 21, 2023 | T414472 | |
| Certificate of Analysis | Sep 21, 2023 | T414472 | |
| Certificate of Analysis | Sep 21, 2023 | T414472 | |
| Certificate of Analysis | Mar 29, 2023 | T414472 | |
| Certificate of Analysis | Mar 29, 2023 | T414472 | |
| Certificate of Analysis | Mar 29, 2023 | T414472 | |
| Certificate of Analysis | Mar 29, 2023 | T414472 | |
| Certificate of Analysis | Mar 29, 2023 | T414472 | |
| Certificate of Analysis | Mar 29, 2023 | T414472 | |
| Certificate of Analysis | Mar 29, 2023 | T414472 | |
| Certificate of Analysis | Mar 29, 2023 | T414472 | |
| Certificate of Analysis | Mar 29, 2023 | T414472 | |
| Certificate of Analysis | Mar 29, 2023 | T414472 |
| Solubility | Solubility (25°C) In vitro DMSO: 88 mg/mL (200.2 mM); Ethanol: 88 mg/mL (200.2 mM); Water: Insoluble; |
|---|---|
| Sensitivity | Light sensitive |
| DMSO(mg / mL) Max Solubility | 88 |
| DMSO(mM) Max Solubility | 200.204754862928 |
| Water(mg / mL) Max Solubility | <1 |
| Molecular Weight | 439.600 g/mol |
| XLogP3 | 5.300 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 439.237 Da |
| Monoisotopic Mass | 439.237 Da |
| Topological Polar Surface Area | 85.700 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 728.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
Starting at $599.90